The KFXL has efficient antifungal activity against vulvovaginal candidiasis in mice in two ways: by inhibiting mycelia growth and development to reduce C. albicans colonization, and by promoting the secretion and release of IL-17A and neutrophils to fight C. albicans infection (Ma et al., 2022). This evidence concerns the gene IL17A and vulvovaginal candidiasis.